Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Reiser

Showing results (91-100 of 242) with videos related to

Pageof 25
Sort By:
BMC Nephrology|December 19, 2018
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximabNada Alachkar, Jing Li, Dany Matar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 19, 2012
Human RAGE antibody protects against AGE-mediated podocyte dysfunctionSandra Müller-Krebs, Lars P Kihm, Thati Madhusudhan, et al.
Cellular Microbiology|April 6, 2021
Pseudomonas aeruginosa ExoT induces G1 cell cycle arrest in melanoma cellsMohamed F Mohamed, Stephen J Wood, Ruchi Roy, et al.
Plos One|August 6, 2010
Establishment of protein delivery systems targeting podocytesWen Chih Chiang, Tessa M Geel, Mehmet M Altintas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 21, 2022
Soluble Urokinase Receptor and Mortality in Kidney Transplant RecipientsChristian Morath, Salim S Hayek, Bernd Döhler, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2017
TRPC5 Does Not Cause or Aggravate Glomerular DiseaseXuexiang Wang, Ranadheer R Dande, Hao Yu, et al.
Journal of Lipid Research|December 15, 2010
Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in miceMehmet M Altintas, Adiba Azad, Behzad Nayer, et al.
Parkinsonism & Related Disorders|July 5, 2022
Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJessica Joyce, Noel Cabanas, Rohan Pisharody, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Novel concepts in understanding and management of glomerular proteinuriaJochen Reiser, Gero von Gersdorff, Matias Simons, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 4, 2013
CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutationGabriel Cara-Fuentes, Carlos Araya, Changli Wei, et al.
Pageof 25

Showing results (91-100 of 242) with videos related to

Sort By:
Pageof 25
BMC Nephrology|December 19, 2018
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximabNada Alachkar, Jing Li, Dany Matar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 19, 2012
Human RAGE antibody protects against AGE-mediated podocyte dysfunctionSandra Müller-Krebs, Lars P Kihm, Thati Madhusudhan, et al.
Cellular Microbiology|April 6, 2021
Pseudomonas aeruginosa ExoT induces G1 cell cycle arrest in melanoma cellsMohamed F Mohamed, Stephen J Wood, Ruchi Roy, et al.
Plos One|August 6, 2010
Establishment of protein delivery systems targeting podocytesWen Chih Chiang, Tessa M Geel, Mehmet M Altintas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 21, 2022
Soluble Urokinase Receptor and Mortality in Kidney Transplant RecipientsChristian Morath, Salim S Hayek, Bernd Döhler, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2017
TRPC5 Does Not Cause or Aggravate Glomerular DiseaseXuexiang Wang, Ranadheer R Dande, Hao Yu, et al.
Journal of Lipid Research|December 15, 2010
Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in miceMehmet M Altintas, Adiba Azad, Behzad Nayer, et al.
Parkinsonism & Related Disorders|July 5, 2022
Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJessica Joyce, Noel Cabanas, Rohan Pisharody, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Novel concepts in understanding and management of glomerular proteinuriaJochen Reiser, Gero von Gersdorff, Matias Simons, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 4, 2013
CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutationGabriel Cara-Fuentes, Carlos Araya, Changli Wei, et al.
Pageof 25